Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relationship between high serum digoxin levels and toxicity

Y Tuncok1, E Hazan, O Oto

  • 1Department of Pharmacology, Medical Faculty, Dokuz Eylul University, Balcova, Izmir, Turkey.

International Journal of Clinical Pharmacology and Therapeutics
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhaled nitric oxide as rescue therapy in severe ARDS cases due to COVID-19 pneumonia: a single center experience.

European review for medical and pharmacological sciences·2023
Same author

Energy and material refineries of future: Wastewater treatment plants.

Journal of environmental management·2022
Same author

Management of mechanical ventilation in a morbidly obese patient with COVID-19-induced ARDS.

European review for medical and pharmacological sciences·2021
Same author

Effects of resveratrol on alpha-amanitin-induced nephrotoxicity in BALB/c mice.

Human & experimental toxicology·2019
Same author

Effects of <i>Nigella sativa</i> oil on ovarian volume, oxidant systems, XIAP and NF-kB expression in an experimental model of diabetes.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2019
Same author

Optical coherence tomography-verified longer balloon inflation time may provide better stent apposition and optimal index parameters.

Herz·2018

High serum digoxin levels (≥3.0 ng/ml) were not strongly linked to clinical toxicity in a retrospective study of 1,269 patients. Most patients tolerated elevated digoxin levels, highlighting the need for careful interpretation of digoxin monitoring.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Toxicology

Background:

  • Digoxin is a crucial medication for heart failure and arrhythmias.
  • Therapeutic drug monitoring of serum digoxin levels is standard practice.
  • Defining toxic digoxin levels requires understanding the correlation between serum concentration and clinical presentation.

Purpose of the Study:

  • To investigate the relationship between elevated serum digoxin levels (≥3.0 ng/ml) and clinical toxicity.
  • To identify factors influencing serum digoxin levels and toxicity.
  • To evaluate the clinical significance of high digoxin levels in a large patient cohort.

Main Methods:

  • Retrospective analysis of 1,269 patients receiving digoxin.
  • Correlation of serum digoxin levels with documented clinical toxicity.

Related Experiment Videos

  • Identification of potential confounding factors such as blood sampling time, cardiac output, concomitant medications, and renal function.

    • Main Results:

    • Only 4.6% of patients had serum digoxin levels ≥3.0 ng/ml.
    • Clinical digoxin toxicity was observed in a small subset of these patients (11/58).
    • Premature blood sampling explained high levels in 10 non-toxic patients; 37 patients tolerated high levels without toxicity. Low cardiac output, polypharmacy, and renal impairment were associated with higher digoxin levels.

    Conclusions:

    • Serum digoxin levels ≥3.0 ng/ml do not invariably indicate clinical toxicity.
    • Factors such as sampling time and patient-specific conditions influence digoxin levels and toxicity risk.
    • Further research is needed to refine the definition of toxic digoxin levels and optimize therapeutic drug monitoring strategies.